Melanoma, a highly aggressive skin cancer, is characterized by rapid progression and high
mortality. Recent advances in molecular pathogenesis have shed light on genetic and …

Malignant melanoma presents a substantial clinical challenge. Current diagnostic methods
are limited in their ability to diagnose early disease and accurately predict individual risk of …

Unraveling the multidimensional complexities of melanoma has required concerted efforts
by dedicated community of researchers and clinicians battling against this deadly form of …

Despite enormous international efforts, skin melanoma is still a major clinical challenge.
Melanoma takes a top place among the most common cancer types and it has one of the …

Melanoma is one of the most aggressive types of skin cancer with rapidly increasing
incidence rate. The disease is largely considered incurable and the patients diagnosed with …

Malignant melanoma is one of the most common cancers in the world. In the disease's early
stages, treatment involves surgery, in advanced stages however, treatment options were …

The incidence of melanoma is increasing at one of the highest rates of any form of cancer in
the United States, with the current lifetime risk being one in 68. At present, there are limited …

Progress in understanding the molecular basis of melanoma has made possible the
identification of molecular targets with important implications in clinical practice. In fact, new …

Metastatic melanoma remained for decades without any effective treatment and was thus
considered as a paradigm of cancer resistance. Recent progress with understanding of the …

Malignant melanoma remains one of the fastest growing cancers worldwide. Although the
primary cutaneous melanoma can be managed by surgery, the advanced metastatic …